MBS638104 | Carcinoembryonic Antigen, Recombinant, Human, 90+% (CEA, CD66e)

(No reviews yet) Write a Review
SKU:
MBS638104
Availability:
Usually Shipped in 5 Working Days
€825.00 - €988.50
Frequently bought together:

Description

Carcinoembryonic Antigen, Recombinant, Human, 90+% (CEA, CD66e) | MBS638104 | MyBiosource

Product Short Name: [Carcinoembryonic Antigen, 90+%]

Product Name Synonyme: N/A

Other Names: [CD48 antigen; CD48 antigen; CD48 antigen; HM48-1; BCM1 surface antigen; SLAM family member 2; MRC OX-45 surface antigen; signaling lymphocytic activation molecule 2; CD48 antigen; BCM1 surface antigen; BLAST-1; HM48-1; MRC OX-45 surface antigen; SLAM family member 2; SLAMF2; Signaling lymphocytic activation molecule 2; sgp-60]

Product Gene Name: N/A

Product Gene Name Synonyme: N/A

Other Gene Names: [Cd48; Cd48; BCM1; BLAST; Bcm-1; BLAST1; SLAMF2; Sgp-60; BLAST-1; MEM-102; AI449234; AW610730; Bcm-1; SLAMF2]

Clonality: N/A

Isotype: N/A

Clone: N/A

Host: N/A

Reactivity: N/A

Specificity: N/A

Purity: Highly Purified
90% by RP-HPLC, FPLC, or reducing/non-reducing SDS-PAGE Silver Stain; Purified by proprietary chromatographic techniques. Endotoxin: 0.1ng/ug (IEU/ug) of Human CEA.

Form: Supplied as a liquid in 10mM sodium phosphate, pH 7.0, 150mM sodium chloride.

Concentration: N/A

Storage Stability: For long-term storage, add 0.1% HSA or BSA, aliqot and store at -20 degree C. Aliquots are stable for at least 6 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Tested Application: N/A

View AllClose